Janette Wider
Articles by Janette Wider
AI Reshapes Job Market: New Priorities for Clinical Labs
Artificial intelligence (AI) is no longer a future consideration in the job market. Instead, it is actively reshaping how professionals find work, how roles are defined, and which skills employers value most. According to recent LinkedIn resear…
January 19, 2026, Intelligence: Late-Breaking Lab News
Entrepreneur Mark Cuban is calling for financial penalties to curb what he describes as systemic overbilling across the US healthcare system, a proposal that could significantly raise the stakes for insurers, hospitals, and clinical laboratories. In a provocative Dec. 24 post on X, Cuba…
FDA Reviews Oncology Companion Diagnostics
CEO SUMMARY: Regulatory attorneys indicate that the FDA’s move to reclassify oncology companion diagnostics to Class II medical devices could speed approvals and reduce costs for submissions. From a business perspective, the proposal could allow clinical laboratories to …
Top Stories in 2025 Played Out in Courts, Capitol Hill
CEO SUMMARY: The biggest story of the year for clinical laboratories came in a huge court victory, as a federal judge vacated the FDA’s final rule on laboratory developed tests. Labs breathed a sigh of relief after the court decision, as the FDA rule had promised to incr…
Redefining Path Reports to Be Patient’s Partner
CEO SUMMARY: The 21st Century Cures Act gave patients immediate access to their pathology report results, prompting pathologists to rethink their role. New research indicates that patients often see their pathology results before their physicians do, creating a gap in cont…
December 29, 2025, Intelligence: Late-Breaking Lab News
The US Department of Veterans Affairs (VA) is expanding its use of precision medicine through a new multi-year contract with Baylor Genetics to provide pharmacogenomic (PGx) and germline genetic testing to veterans across the VA’s nationwide healthcare system. The agreement includes P…
Labs Enter a Critical PAMA Reform Window
CEO SUMMARY: A reprieve of upcoming PAMA cuts to lab test reimbursement rates is official with an extension through Jan. 30, 2026. This, however, is not a lot of time and pressure is on the clinical laboratory industry to get the RESULTS Act passed to permanently reform PAMA. Lab indust…
Labs Enter a Critical PAMA Reform Window
CEO SUMMARY: A reprieve of upcoming PAMA cuts to lab test reimbursement rates is official with an extension through Jan. 30, 2026. This, however, is not a lot of time and pressure is on the clinical laboratory industry to get the RESULTS Act passed to permanently reform PA…
How Stanford Tackles the Lab Labor Shortage
CEO SUMMARY: Clinical labs nationwide face worsening staffing shortages across all roles. Stanford Health Care’s Jennifer Fralick outlines strategies to retain talent and improve efficiency, such as career ladders and top-of-skills staffing. By aligning tasks with skill …
CAP Regains VA Lab Accreditation Contract
CEO SUMMARY: In a blow to The Joint Commission, the US Department of Veterans Affairs has awarded a new clinical laboratory accreditation contract to the College of American Pathologists (CAP). The decision highlights the competition between the two accrediting organizatio…
CURRENT ISSUE
Volume XXXIII, No. 1 – January 19, 2026
The Dark Report looks at the FDA’s move to reclassify Oncology companion diagnostics as Class II medical devices and considers how labs can benefit. Also, observers are concerned about the effect of PAMA cuts on rural clinical laboratories.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.